首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Effect of (S)-4-(1-(5-Chloro-2-(4-fluorophenyoxy)benzamido)ethyl) Benzoic Acid (CJ-42794), a Selective Antagonist of Prostaglandin E Receptor Subtype 4, on Ulcerogenic and Healing Responses in Rat Gastrointestinal Mucosa
【24h】

Effect of (S)-4-(1-(5-Chloro-2-(4-fluorophenyoxy)benzamido)ethyl) Benzoic Acid (CJ-42794), a Selective Antagonist of Prostaglandin E Receptor Subtype 4, on Ulcerogenic and Healing Responses in Rat Gastrointestinal Mucosa

机译:前列腺素E受体亚型4的选择性拮抗剂(S)-4-(1-(5-氯-2-(4-氟苯氧基)苯甲酰胺基)乙基)苯甲酸(CJ-42794)对致溃疡和愈合反应的影响在大鼠胃肠道粘膜

获取原文
获取原文并翻译 | 示例
           

摘要

Recent research showed the involvement of prostaglandin E receptor subtype 4 (EP4) in hypersensitivity to inflammatory pain and suggested that the EP4 receptor is a potential target for the pharmacological treatment of inflammatory pain. We examined the effects of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy) benzamido)ethyl) benzoic acid (CJ-42794), a selective EP4 antagonist, on gastrointestinal ulcerogenic and healing responses in rats, in comparison with those of various cyclooxygenase (COX) inhibitors. CJ-42794 alone, given p.o., did not produce any damage in the gastrointestinal mucosa, similar to 5-(4-chlorophenyl)-1-(4-methoxy-phenyl)-3-(trifluoromethyl)-1H-pyrazole (SC-560) (COX-1 inhibitor) or rofecoxib (COX-2 inhibitor), whereas indomethacin (nonselective COX inhibitor) caused gross lesions. Rofecoxib but not CJ-42794, however, damaged these tissues when coadministered with SC-560 and aggravated gastric lesions produced by aspirin. Indomethacin and SC-560 worsened the gastric ulcerogenic response to cold-restraint stress, yet neither CJ-42794 nor rofecoxib had any effect. Furthermore, indomethacin and SC-560 at lower doses damaged the stomach and small intestine of adjuvant arthritic rats. In arthritic rats, rofecoxib but not CJ-42794 provoked gastric ulceration, whereas CJ-42794 produced little damage in the small intestine. The repeated administration of CJ-42794 and rofecoxib as well as indomethacin impaired the healing of chronic gastric ulcers with a down-regulation of vascular endothelial growth factor expression in the ulcerated mucosa. These results suggest that CJ-42794 does not cause any damage in the normal rat gastrointestinal mucosa and in the arthritic rat stomach and does not worsen the gastric ulcerogenic response to stress or aspirin in normal rats, although this agent slightly damages the small intestine of arthritic rats and impairs the healing of gastric ulcers.
机译:最近的研究表明,前列腺素E受体亚型4(EP4)参与了对炎性疼痛的超敏反应,并表明EP4受体是炎性疼痛药理治疗的潜在靶标。我们研究了选择性EP4拮抗剂(S)-4-(1-(5-氯-2-(4-氟苯氧基)苯甲酰氨基)乙基)苯甲酸(CJ-42794)对胃肠道溃疡发生和愈合反应的影响与各种环氧合酶(COX)抑制剂相比。单独给予CJ-42794,不会对胃肠道粘膜产生任何损害,类似于5-(4-氯苯基)-1-(4-甲氧基-苯基)-3-(三氟甲基)-1H-吡唑(SC- 560)(COX-1抑制剂)或rofecoxib(COX-2抑制剂),而消炎痛(非选择性COX抑制剂)引起严重病变。当与SC-560并用时,罗非昔布而非CJ-42794损害了这些组织,并加剧了阿司匹林引起的胃部病变。消炎痛和SC-560加重了胃对冷约束应激的溃疡致病反应,但CJ-42794和罗非考昔都没有作用。此外,消炎痛和低剂量的SC-560会损害佐剂关节炎大鼠的胃和小肠。在关节炎大鼠中,罗非考昔而不是CJ-42794引起胃溃疡,而CJ-42794在小肠中几乎没有产生损伤。反复施用CJ-42794和罗非考昔以及消炎痛会损害溃疡性粘膜中血管内皮生长因子的表达,从而损害慢性胃溃疡的愈合。这些结果表明,CJ-42794不会在正常大鼠的胃肠道粘膜和关节炎大鼠的胃中造成任何损害,并且不会使正常大鼠的胃对压力或阿司匹林的胃溃疡反应恶化,尽管这种药物会轻微损害关节炎的小肠。大鼠并损害胃溃疡的愈合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号